Karolinska Development AB (publ) (STO:KDEV)
Sweden · Delayed Price · Currency is SEK 0.2995
-0.0105 (-3.39%)
Jan 21, 2026, 5:29 PM CET
Karolinska Development AB Revenue
Karolinska Development AB had revenue of 322.00K SEK in the quarter ending September 30, 2025, a decrease of -16.80%. This brings the company's revenue in the last twelve months to 1.74M, down -7.45% year-over-year. In the year 2024, Karolinska Development AB had annual revenue of 1.84M, down -8.74%.
Revenue (ttm)
1.74M
Revenue Growth
-7.45%
P/S Ratio
48.13
Revenue / Employee
217.25K
Employees
8
Market Cap
83.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.84M | -176.00K | -8.74% |
| Dec 31, 2023 | 2.01M | -286.00K | -12.43% |
| Dec 31, 2022 | 2.30M | 130.00K | 5.99% |
| Dec 31, 2021 | 2.17M | -481.00K | -18.14% |
| Dec 31, 2020 | 2.65M | -733.00K | -21.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Vimian Group AB | 4.65B |
| Vitrolife AB | 3.51B |
Karolinska Development AB News
- 7 weeks ago - Karolinska Development Launches Rights Issue To Fund Portfolio Growth - Nasdaq
- 1 year ago - Karolinska Development’s portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO - Business Upturn